DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population
Kocabas, N. A.
International Institute of Anticancer Research
4955 - 4958
Item Usage Stats
MetadataShow full item record
Background: Occupational exposure and life style preferences, such as smoking are the main known environmental susceptibility factors for bladder cancer. A growing list of chemicals has been shown to induce oxidative DNA damage. Base excision repair (BER) genes (X-ray repair cross complementing 1, XRCC1 and human 8-oxoguanine DNA glycosylase 1, OGG1) may play a key role in maintaining genome integrity and preventing cancer development. Materials and Methods: We tested whether polymorphisms in XRCC1 and OGG1 are associated with bladder cancer risk by using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) assay. In addition, the possible modifying affect of cigarette smoking was evaluated. Results: No studies, to date, have examined the association between genetic polymorphisms in DNA repair genes and bladder cancer susceptibility, in the Turkish population. We found the OGG1 Cys326Cys genotype to be more frequent among bladder cancer patients (odds ratio (OR): 2.41 (95% CI, 1.36-4.25)). However, in the case of XRCC1, there was no significant difference in susceptibility to bladder cancer development between patients with the Arg399 and these with the Gln399 allele (OR: 0.72 (95% CI, 0.41-1.26)). Conclusion: Our data showed that OGG1 genetic polymorphisms might be useful as prognostic genetic markers for bladder cancer in the clinical setting.
Protein 8 oxoguanine dna glycosylase 1
Protein x ray repair cross complementing 1
Major clinical study
Polymerase chain reaction
Restriction fragment length polymorphism
Aged, 80 and over
Genetic predisposition to disease
Polymerase Chain Reaction
Polymorphism, Restriction fragment length
Urinary bladder neoplasms
Showing items related by title, author, creator and subject.
Koytak, E.S.; Mizrak, D.; Bektaş, M.; Verdi H.; Ergül, A.A.; Idilman, R.; Çinar, K.; Yurdaydin, C.; Ersöz, S.; Karayalçin, K.; Uzunalimoǧlu Ö.; Bozkaya H. (2008)Background/aims: Several lines of evidence suggest that peroxisome proliferator-activated receptor alpha may be involved in hepatocarcinogenesis. L162V polymorphism of the peroxisome proliferator-activated receptor alpha ...
Onat, O. E.; Tez, M.; Özçelik, T.; Törüner, G. A. (International Institute of Anticancer Research, 2006)Recently, a functional T to G polymorphism at nucleotide 309 in the promoter region of the MDM2 gene (rs: 2279744, SNP 309) has been identified. This polymorphism has an impact on the expression of the MDM2 gene, which is ...
p53 codon 72 polymorphism in bladder cancer-No evidence of association with increased risk or invasiveness Törüner, G. A.; Uçar, A.; Tez, M.; Çetinkaya, M.; Özen, H.; Özçelik, T. (Springer, 2001)We studied the effect of the p53 gene Arg72Pro polymorphism on bladder cancer susceptibility in a case control study of 121 bladder cancer patients and 114 age-sex matched controls to determine whether this polymorphism ...